Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab Treatment

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F18%3A10383005" target="_blank" >RIV/00216208:11150/18:10383005 - isvavai.cz</a>

Alternative codes found

RIV/00179906:_____/18:10383005

Result on the web

<a href="http://doi.org/10.1016/j.clinthera.2018.09.004" target="_blank" >http://doi.org/10.1016/j.clinthera.2018.09.004</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.clinthera.2018.09.004" target="_blank" >10.1016/j.clinthera.2018.09.004</a>

Result language

angličtina

Original language name

Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab Treatment

Original language description

Omalizumab has demonstrated clinical efficacy in severe allergic asthma by reducing exacerbation rates and increasing quality of life. However, data concerning its sustained effect after treatment discontinuation are still needed. Omalizumab treatment exhibited sustained treatment benefit after its discontinuation for patients experiencing severe allergic asthma.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30225 - Allergy

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Clinical Therapeutics

ISSN

0149-2918

e-ISSN

—

Volume of the periodical

40

Issue of the periodical within the volume

11

Country of publishing house

US - UNITED STATES

Number of pages

12

Pages from-to

1942-1953

UT code for WoS article

000452248500016

EID of the result in the Scopus database

2-s2.0-85055733785